Fiera Capital (Canada)
MRTX

Fiera Capital (Canada)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Fiera Capital (Canada)’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,038,836
Closed -$45.3M – 547
2023
Q3 		$45.3M Buy
1,038,836
+346,803
+50% +$12.4M 0.14% 88
2023
Q2 		$25M Sell
692,033
-17,494
-2% -$721K 0.07% 138
2023
Q1 		$26.4M Buy
709,527
+16,870
+2% +$759K 0.08% 132
2022
Q4 		$31.4M Buy
692,657
+159,307
+30% +$10.3M 0.1% 112
2022
Q3 		$37.2M Sell
533,350
-6,735
-1% -$498K 0.13% 87
2022
Q2 		$36.3M Buy
540,085
+259,368
+92% +$16.5M 0.11% 99
2022
Q1 		$23.1M Buy
+280,717
New +$28.7M 0.06% 157

Other funds holding MRTX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
B
Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return

Fiera Capital (Canada)'s MRTX Position: Q4 2023 in Review

Fiera Capital (Canada) sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2023, closing a stake of 1,038,836 shares — an estimated $45.3M sold.

Fiera Capital (Canada) first reported a position in MRTX in Q1 2022 and held it in 7 quarters. The position peaked at $45.3M in Q3 2023. 217 funds tracked by Wall St. Rank hold MRTX as of Q4 2023.

  • Fiera Capital (Canada) reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,038,836 Mirati Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $45.3M.
  • Fiera Capital (Canada) first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Fiera Capital (Canada)'s Mirati Therapeutics, Inc. Common Stock position peaked at $45.3M in Q3 2023.
  • 217 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2023, filed 8 Feb 2024.